BACKGROUND: Neutral lipid storage disease with myopathy (NLSDM) is a rare genetic myopathy caused by mutations in the patatin-like phospholipase domain-containing protein (PNPLA2) gene. To date, the number of reported cases remains limited and the correlation between disease phenotypes and genotypes remains unclear. RESULTS: Our study presents eight NLSDM patients from a Chinese neuromuscular center, identifying two PNPLA2 novel mutations through next-generation sequencing. Demographic and clinical data, as well as information from muscle electrophysiological, imaging, pathological, and genetic analyses, were collected. Several patients in the cohort were found to have right upper extremity weakness as the initial clinical manifestation. Notably, the first patient with facial muscle involvement was reported in this series. Muscle histopathology revealed a characteristic accumulation of lipid droplets predominantly in type 1 muscle fibers, featuring type 1 fiber atrophy concurrent with type 2 fiber hypertrophy, which was systematically described first in a summary manner. CONCLUSIONS: This study prompted us to summarize abnormal clinicopathological features and explore the relationship between gene mutations and disease phenotypes in NLSDM.
Clinicopathological-genetic features of neutral lipid storage disease with myopathy from a Chinese neuromuscular center.
来自中国神经肌肉中心的伴有肌病的脂质中性贮积症的临床病理遗传特征
阅读:17
作者:Luan Yi-Ning, Shi Guan-Zhong, Li Qiu-Xiang, Huang Kun, Yang Huan
| 期刊: | Orphanet Journal of Rare Diseases | 影响因子: | 3.500 |
| 时间: | 2025 | 起止号: | 2025 Jul 1; 20(1):322 |
| doi: | 10.1186/s13023-025-03861-7 | 研究方向: | 神经科学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
